핵심요약

• 애브비는 연초부터 5% 하락했지만, 주요 성장 동력인 스카이리지와 린보크가 다음 decade까지 성장 동력으로 작용할 전망입니다.
• 월마트는 최신 실적 발표 후 주가가 하락했지만, 베컨 딕슨은 1.67% 상승세입니다.
• 애브비는 Dividend Kings에 속하며, 50년 연속 배당금 증가 기록을 보유하고 있습니다.
• 애브비의 주요 제품에는 보톡스 프랜차이즈 등이 포함되며, 무게 감량 시장에서의 잠재력도 있습니다.
• 월마트는 최신 실적 발표 후 주가가 하락했지만, 베컨 딕슨은 1.67% 상승세입니다.

도입

이 기사는 인공지능 분야의 성장 가능성에 집중하는 투자자들에게 배당주 투자의 중요성을 상기시켜줍니다. 특히 애브비, 월마트, 베컨 딕슨과 같은 안정적인 배당주를 매수하는 것이 장기적인 수익을 확보하는 데 도움이 될 수 있습니다. 이러한 기업들은 안정적인 배당 정책과 성장 잠재력을 동시에 보유하고 있어, 포트폴리오 다각화에 적합합니다.

본문 1: 애브비의 성장 동력 분석

애브비는 연초부터 5% 하락했지만, 주요 성장 동력인 스카이리지와 린보크가 다음 decade까지 성장 동력으로 작용할 전망입니다. 애브비의 1분기 실적은 기대치를 상회했으며, 이는 회사 내부의 강력한 재무 상태를 반영합니다. 또한, 애브비는 보톡스 프랜차이즈와 같은 다양한 제품 포트폴리오를 보유하고 있어, 다양한 시장에서의 수익을 기대할 수 있습니다. 이러한 점들을 고려할 때, 애브비는 장기적인 투자 대상으로 적합합니다.

본문 2: 월마트의 실적과 전망

월마트는 최신 실적 발표 후 주가가 하락했지만, 이는 단기적인 시장 반응일 수 있습니다. 월마트의 실적 자체는 그리 나쁘지 않았으며, 장기적인 성장 가능성은 여전히 존재합니다. 다만, 투자자들은 월마트의 미래 전망에 대해 신중해야 합니다. 월마트는 여전히 강력한 브랜드와 시장 점유율을 보유하고 있지만, 경쟁사들과의 경쟁이 치열해지고 있는 점도 고려해야 합니다.

본문 3: 베컨 딕슨의 상승세 분석

베컨 딕슨은 1.67% 상승세로 주목받고 있습니다. 이는 회사의 강력한 재무 상태와 성장 잠재력을 반영한 것입니다. 베컨 딕슨은 의료 분야에서 중요한 위치를 차지하고 있으며, 앞으로도 지속적인 성장을 기대할 수 있습니다. 이러한 점들을 고려할 때, 베컨 딕슨은 장기적인 투자 대상으로 적합합니다.

결론

이 기사는 인공지능 분야의 성장 가능성에 집중하는 투자자들에게 배당주 투자의 중요성을 상기시켜줍니다. 특히 애브비, 월마트, 베컨 딕슨과 같은 안정적인 배당주를 매수하는 것이 장기적인 수익을 확보하는 데 도움이 될 수 있습니다. 이러한 기업들은 안정적인 배당 정책과 성장 잠재력을 동시에 보유하고 있어, 포트폴리오 다각화에 적합합니다. 향후 이러한 기업들의 실적과 시장 동향을 주의 깊게 관찰하는 것이 중요합니다.

---

원문 링크: https://www.fool.com/investing/2026/06/22/3-excellent-dividend-stocks-to-buy-on-the-dip/?.tsrc=rss

3 Excellent Dividend Stocks to Buy on the Dip

Many investors are chasing life-changing gains by buying shares in top artificial intelligence companies. That makes sense. The industry could offer (and already has offered) multiple transformative investment opportunities. It's a great idea to try to capitalize on this. However, it's also important not to forget about other proven strategies for earning solid long-term returns, one of which is to invest in strong dividend-paying corporations. With that in mind, let's consider three dividend stocks that are worth buying right now: AbbVie ( ABBV 2.05% ) , Walmart ( WMT 0.72% ) , and Becton, Dickinson ( BDX +1.67% ) .

AbbVie, a leading pharmaceutical company , has not performed well this year. The company's shares are down 5% year to date. However, that has as much to do with broader weakness in the healthcare sector as anything AbbVie did wrong. In fact, the company's financial results have been pretty strong. The drugmaker exceeded expectations in the first quarter. Further, AbbVie's long-term outlook remains bright. The company's two main growth pillars, Skyrizi and Rinvoq, continue to defy expectations and should remain important growth drivers into the next decade.

AbbVie has several other important products, including its Botox franchise, among others. The company also has a deep pipeline, with several exciting products that could eventually become meaningful growth drivers, including in the weight loss market. AbbVie has overcome significant patent cliffs in the past and should do so again, thanks to its innovative qualities. Finally, AbbVie is a fantastic dividend stock. It is a member of the Dividend Kings , a group of companies that have achieved at least 50 consecutive years of payout increases. All these factors make AbbVie a solid dividend stock to buy and hold onto for a while.

Walmart's shares dropped significantly after its latest earnings. Though its results were pretty good, the company's outlook did not inspire confidence. There is no question that Walmart may have a rough go of it in the near term. Broader economic problems, such as inflation and tariffs, may lead to lower foot traffic in its stores and overall unimpressive sales. However, it remains an excellent stock to buy and hold. Here are three reasons why. First, even in the current environment that will be unfriendly to much of the retail industry , Walmart should perform better than most of its peers thanks to its ability to offer competitive prices. Walmart is known for its Everyday Low Price guarantee, and combined with its significant retail footprint, it should help the company generate somewhat decent sales and earnings even if we enter a recession.

Second, Walmart is tapping into important long-term opportunities that should help improve its profits and margins. The company's higher-margin e-commerce operations have been growing faster than the rest of the business for years and are also helping it ramp up its digital advertising unit, another highly profitable business. Both e-commerce and digital advertising have a long runway for growth, and that's great news for Walmart. Finally, the company also has an impressive dividend track record. It has recorded 53 consecutive years of dividend increases, making it a Dividend King. Walmart is a great income play for investors focused on the long haul.

Becton, Dickinson has been facing challenges for years. Between broader economic problems and slow revenue and earnings growth, the company's shares have lagged the market. However, the stock could still deliver competitive returns -- especially with dividends reinvested -- for investors willing to be patient. Despite the headwinds it has faced, the medical device specialist remains a leader in its niche, providing a range of devices and tools healthcare professionals use regularly. The list includes items such as needles and syringes, specimen collection tools, infusion systems, and more.

Crucially, over 90% of the company's revenue is from recurring consumables. Also, the company has spun off several parts of the business -- including most recently its biosciences and diagnostic solutions segment. Getting rid of this lower growth unit should help boost the company's sales growth.

Further, Becton, Dickinson has several attractive opportunities, one of the most important being in the GLP-1 market. The company provides pharmaceutical leaders with prefillable syringes that patients use to inject themselves with GLP-1 medications. Becton, Dickinson set a goal of reaching $1 billion in GLP-1-related revenue by the end of the decade, and the company said earlier this year that it was almost halfway there. Beyond that, Becton, Dickinson's innovative qualities should help it pounce on other growth avenues. Finally, the company is also a Dividend King, having raised its payouts for 54 consecutive years. It'd be a great move for dividend seekers to buy this company's shares on the dip.

Source: https://www.fool.com/investing/2026/06/22/3-excellent-dividend-stocks-to-buy-on-the-dip/?.tsrc=rss